TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

OPINION

Kerzner Profit Falls, Beats

PRESS RELEASES

Kezar Life Sciences Added To The Nasdaq Biotechnology Index

PRESS RELEASES

Kezar Life Sciences To Present During Upcoming Virtual Investor Conferences

PRESS RELEASES

Kezar Highlights Broad Therapeutic Potential Of KZR-616 During ACR Convergence 2020

PRESS RELEASES

Kezar Life Sciences Announces Orphan Drug Designations For KZR-616 For The Treatment Of Polymyositis And Dermatomyositis

PRESS RELEASES

Kezar Life Sciences To Present At Four Upcoming Virtual Medical And Scientific Conferences

PRESS RELEASES

Kezar Life Sciences To Present At The Myositis Association International Annual Patient Conference And The Pan-American Congress Of Rheumatology

PRESS RELEASES

Kezar Life Sciences To Participate In Two Upcoming Virtual Investor Conferences

PRESS RELEASES

Kezar Life Sciences To Release Second Quarter Financial Results And General Business Updates On August 5, 2020

PRESS RELEASES

Kezar Announces Pricing Of A Public Offering Of $46.7 Million Of Common Stock And Pre-Funded Warrants

PRESS RELEASES

Kezar Announces Proposed Public Offering Of Common Stock

PRESS RELEASES

Kezar Life Sciences To Participate In Fireside Chat During The Jefferies Virtual Healthcare Conference

PRESS RELEASES

Kezar Announces Presentations During Upcoming Scientific Conferences

PRESS RELEASES

Kezar Life Sciences Strengthens Executive Team With The Appointment Of Noreen R. Henig, MD As Chief Medical Officer

PRESS RELEASES

Kezar Provides Statement Regarding COVID-19 Pandemic

PRESS RELEASES

Kezar Life Sciences To Present At Cowen And Company's 40th Annual Healthcare Conference

PRESS RELEASES

Kezar Announces Closing Of $56.8 Million Public Offering Of Common Stock And Pre-Funded Warrants

PRESS RELEASES

Kezar Announces Pricing Of $49.4 Million Public Offering Of Common Stock And Pre-Funded Warrants

PRESS RELEASES

Kezar Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants

OPINION

Kerzner Profit Falls, Beats